Salvatore Alesci
Corporate Officer/Principal presso TAKEDA PHARMACEUTICAL COMPANY LIMITED
Posizioni attive di Salvatore Alesci
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Direttore Tecnico/Scientifico/R&S | 01/01/2022 | - |
Storia della carriera di Salvatore Alesci
Statistiche
Distribuzione geografica
| Giappone | 2 |
| Stati Uniti | 2 |
Posizioni
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
- Borsa valori
- Insiders
- Salvatore Alesci
- Esperienza
